dehydroepiandrosterone has been researched along with Primary Ovarian Insufficiency in 26 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Primary Ovarian Insufficiency: Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Preliminary reports have shown encouraging effects of dehydroepiandrosterone (DHEA) in women with poor ovarian reserve undergoing assisted reproduction and primary ovarian insufficiency (POI), although data from randomized controlled trials are limited." | 9.17 | A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency. ( Ho, PC; Lee, VC; Li, RH; Ng, EH; Yeung, TW, 2013) |
| "Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI)." | 7.91 | Dehydroepiandrosterone supplementation attenuates ovarian ageing in a galactose-induced primary ovarian insufficiency rat model. ( Akouri, R; Demir, N; Erman, M; Gunduz, T; Ozekinci, M; Sozen, B, 2019) |
| "Preliminary reports have shown encouraging effects of dehydroepiandrosterone (DHEA) in women with poor ovarian reserve undergoing assisted reproduction and primary ovarian insufficiency (POI), although data from randomized controlled trials are limited." | 5.17 | A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency. ( Ho, PC; Lee, VC; Li, RH; Ng, EH; Yeung, TW, 2013) |
| " Dehydroepiandrosterone (DHEA) has been reported to improve pregnancy chances with DOR, and is now utilized by approximately one third of all IVF centers world-wide." | 4.87 | Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). ( Barad, DH; Gleicher, N, 2011) |
| "To present the possible positive effect of dehydroepiandrosterone administration in assisted reproduction and especially in poor responders, women with diminished ovarian reserve, premature ovarian failure and premature ovarian aging in the course of ovarian stimulation protocols followed either by intrauterine insemination or IVF." | 4.85 | Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results. ( Mamas, E; Mamas, L, 2009) |
| "Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI)." | 3.91 | Dehydroepiandrosterone supplementation attenuates ovarian ageing in a galactose-induced primary ovarian insufficiency rat model. ( Akouri, R; Demir, N; Erman, M; Gunduz, T; Ozekinci, M; Sozen, B, 2019) |
| "Dehydroepiandrosterone (DHEA) has been proposed as a treatment for improving ovarian reserve in poor responding women undergoing IVF." | 1.38 | DHEA for poor responders: can treatment be justified in the absence of evidence? ( Urman, B; Yakin, K, 2012) |
| "Women with premature ovarian failure (POF) did not show the same androgen profile as postmenopausal women." | 1.33 | Evaluation of serum androgen levels in women with premature ovarian failure. ( Bedone, AJ; Benetti-Pinto, CL; Magna, LA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.85) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 15 (57.69) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Sozen, B | 1 |
| Ozekinci, M | 1 |
| Erman, M | 1 |
| Gunduz, T | 1 |
| Demir, N | 1 |
| Akouri, R | 1 |
| Ozcil, MD | 1 |
| Wong, QHY | 1 |
| Yeung, TWY | 1 |
| Yung, SSF | 1 |
| Ko, JKY | 1 |
| Li, HWR | 1 |
| Ng, EHY | 1 |
| Dragojević Dikić, S | 1 |
| Vasiljević, M | 1 |
| Jovanović, A | 1 |
| Dikić, S | 1 |
| Jurišić, A | 1 |
| Srbinović, L | 1 |
| Vujović, S | 1 |
| Ott, J | 1 |
| Pecnik, P | 1 |
| Promberger, R | 1 |
| Pils, S | 1 |
| Seemann, R | 1 |
| Hermann, M | 1 |
| Frigo, P | 1 |
| Fenton, A | 1 |
| Panay, N | 2 |
| Fusi, FM | 1 |
| Ferrario, M | 1 |
| Bosisio, C | 1 |
| Arnoldi, M | 1 |
| Zanga, L | 1 |
| Ben-Nagi, J | 1 |
| Barad, DH | 5 |
| Kushnir, VA | 1 |
| Lee, HJ | 1 |
| Lazzaroni, E | 1 |
| Gleicher, N | 6 |
| Lin, LT | 1 |
| Tsui, KH | 1 |
| Wang, PH | 1 |
| Bachelot, A | 1 |
| Nicolas, C | 1 |
| Bidet, M | 1 |
| Dulon, J | 1 |
| Leban, M | 1 |
| Golmard, JL | 1 |
| Polak, M | 1 |
| Touraine, P | 1 |
| Weghofer, A | 2 |
| Mamas, L | 2 |
| Mamas, E | 2 |
| Younis, JS | 1 |
| Urman, B | 1 |
| Yakin, K | 1 |
| Kim, A | 1 |
| Yeung, TW | 1 |
| Li, RH | 1 |
| Lee, VC | 1 |
| Ho, PC | 1 |
| Ng, EH | 1 |
| Benetti-Pinto, CL | 1 |
| Bedone, AJ | 1 |
| Magna, LA | 1 |
| Skałba, P | 1 |
| Bednarska-Czerwińska, A | 1 |
| Wójtowicz, M | 1 |
| Lewandowski, P | 1 |
| Mason, A | 1 |
| Wallace, AM | 1 |
| Macintyre, H | 1 |
| Teoh, YP | 1 |
| Bath, LE | 1 |
| Critchley, HO | 1 |
| Kelnar, CJ | 1 |
| Wallace, WH | 1 |
| Ahmed, SF | 1 |
| Check, JH | 1 |
| Barad, D | 1 |
| Brill, H | 1 |
| Elias, AN | 1 |
| Pandian, MR | 1 |
| Rojas, FJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Drospirenone and Ethinyl Estradiol Combinations (Yasmin) as Infertility Treatments for Premature Ovarian Failure: a Perspective Follow-up Study.[NCT02757469] | 20 participants (Anticipated) | Interventional | 2016-05-31 | Not yet recruiting | |||
| To Investigate the Effectiveness of Adjuvant Supplements Prior to in Vitro Fertilization Cycles[NCT05471453] | 90 participants (Anticipated) | Interventional | 2022-03-02 | Recruiting | |||
| The Role of Dehydroepiandrosterone in the Maintenance of Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders[NCT03438812] | 66 participants (Actual) | Interventional | 2017-09-06 | Completed | |||
| Ovarian Needle Puncture for Follicle Activation in IVF Patients With Diminished Ovarian Reserve[NCT04608695] | 34 participants (Anticipated) | Interventional | 2020-07-01 | Recruiting | |||
| The Use of DHEA in Women With Premature Ovarian Failure[NCT01129947] | Early Phase 1 | 0 participants (Actual) | Interventional | 2010-05-31 | Withdrawn (stopped due to very poor patient recruitement) | ||
| Effect of Dehydroepiandrosterone on Live Birth Rate in Subfertile Patients With Poor Ovarian Responds[NCT02432248] | 350 participants (Anticipated) | Interventional | 2015-02-28 | Recruiting | |||
| A Randomized Controlled Trial on the Effect of Dehydroepiandrosterone (DHEA) Supplementation on Ovarian Reserve Markers, Response to a Standard Low Dose FSH Stimulation and IVF Cycle Outcomes in Patients With Normal and Poor Ovarian Reserve[NCT01915186] | 104 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| Does DHEA Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response According to the Bologna Criteria? A Randomized Controlled Study[NCT02151006] | Phase 3 | 140 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
| The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation on the Number of Oocytes Obtained During IVF in Poor Ovarian Responders[NCT02357472] | Phase 4 | 50 participants (Anticipated) | Interventional | 2014-12-31 | Active, not recruiting | ||
| The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve[NCT01129830] | Early Phase 1 | 200 participants (Actual) | Interventional | 2010-01-31 | Terminated (stopped due to Suboptimal recruitment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for dehydroepiandrosterone and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Premature ovarian insufficiency: how to improve reproductive outcome?
Topics: Adjuvants, Immunologic; Clomiphene; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Female; | 2014 |
Premature ovarian insufficiency: how to improve reproductive outcome?
Topics: Adjuvants, Immunologic; Clomiphene; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Female; | 2014 |
Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
Topics: Dehydroepiandrosterone; Female; Fertilization in Vitro; Humans; Ovary; Primary Ovarian Insufficiency | 2015 |
Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
Topics: Dehydroepiandrosterone; Female; Fertilization in Vitro; Humans; Ovary; Primary Ovarian Insufficiency | 2015 |
Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
Topics: Dehydroepiandrosterone; Female; Fertilization in Vitro; Humans; Ovary; Primary Ovarian Insufficiency | 2015 |
Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
Topics: Dehydroepiandrosterone; Female; Fertilization in Vitro; Humans; Ovary; Primary Ovarian Insufficiency | 2015 |
Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
Topics: Dehydroepiandrosterone; Female; Fertilization in Vitro; Humans; Ovary; Primary Ovarian Insufficiency | 2015 |
Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
Topics: Dehydroepiandrosterone; Female; Fertilization in Vitro; Humans; Ovary; Primary Ovarian Insufficiency | 2015 |
Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
Topics: Dehydroepiandrosterone; Female; Fertilization in Vitro; Humans; Ovary; Primary Ovarian Insufficiency | 2015 |
Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
Topics: Dehydroepiandrosterone; Female; Fertilization in Vitro; Humans; Ovary; Primary Ovarian Insufficiency | 2015 |
Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results.
Topics: Age Factors; Aging; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Infertility, F | 2009 |
Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results.
Topics: Age Factors; Aging; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Infertility, F | 2009 |
Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results.
Topics: Age Factors; Aging; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Infertility, F | 2009 |
Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results.
Topics: Age Factors; Aging; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Infertility, F | 2009 |
Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results.
Topics: Age Factors; Aging; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Infertility, F | 2009 |
Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results.
Topics: Age Factors; Aging; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Infertility, F | 2009 |
Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results.
Topics: Age Factors; Aging; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Infertility, F | 2009 |
Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results.
Topics: Age Factors; Aging; Dehydroepiandrosterone; Female; Fertility Agents, Female; Humans; Infertility, F | 2009 |
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
Topics: Animals; Cell Count; Dehydroepiandrosterone; Female; Fertility Agents, Female; Hormone Replacement T | 2011 |
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
Topics: Animals; Cell Count; Dehydroepiandrosterone; Female; Fertility Agents, Female; Hormone Replacement T | 2011 |
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
Topics: Animals; Cell Count; Dehydroepiandrosterone; Female; Fertility Agents, Female; Hormone Replacement T | 2011 |
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
Topics: Animals; Cell Count; Dehydroepiandrosterone; Female; Fertility Agents, Female; Hormone Replacement T | 2011 |
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
Topics: Animals; Cell Count; Dehydroepiandrosterone; Female; Fertility Agents, Female; Hormone Replacement T | 2011 |
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
Topics: Animals; Cell Count; Dehydroepiandrosterone; Female; Fertility Agents, Female; Hormone Replacement T | 2011 |
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
Topics: Animals; Cell Count; Dehydroepiandrosterone; Female; Fertility Agents, Female; Hormone Replacement T | 2011 |
Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR).
Topics: Animals; Cell Count; Dehydroepiandrosterone; Female; Fertility Agents, Female; Hormone Replacement T | 2011 |
Ovarian aging and implications for fertility female health.
Topics: Adult; Aging; Dehydroepiandrosterone; Diagnostic Techniques, Obstetrical and Gynecological; Female; | 2012 |
Ovarian aging and implications for fertility female health.
Topics: Adult; Aging; Dehydroepiandrosterone; Diagnostic Techniques, Obstetrical and Gynecological; Female; | 2012 |
Pharmacological options in resistent ovary syndrome and premature ovarian failure.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Amenorrhea; Dehydroepiandrosterone; Female; Fertili | 2006 |
Pharmacological options in resistent ovary syndrome and premature ovarian failure.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Amenorrhea; Dehydroepiandrosterone; Female; Fertili | 2006 |
3 trials available for dehydroepiandrosterone and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
DHEA supplementation positively affects spontaneous pregnancies in women with diminished ovarian function.
Topics: Adult; Cohort Studies; Dehydroepiandrosterone; Drug Administration Schedule; Female; Fertilization i | 2013 |
DHEA supplementation positively affects spontaneous pregnancies in women with diminished ovarian function.
Topics: Adult; Cohort Studies; Dehydroepiandrosterone; Drug Administration Schedule; Female; Fertilization i | 2013 |
A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
Topics: Adult; Algorithms; Biomarkers; Dehydroepiandrosterone; Double-Blind Method; Drug Administration Sche | 2013 |
A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
Topics: Adult; Algorithms; Biomarkers; Dehydroepiandrosterone; Double-Blind Method; Drug Administration Sche | 2013 |
[Serum androgens concentrations in women with idiopathic premature ovarian failure].
Topics: Adult; Androgens; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Luteinizing | 2006 |
[Serum androgens concentrations in women with idiopathic premature ovarian failure].
Topics: Adult; Androgens; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Luteinizing | 2006 |
17 other studies available for dehydroepiandrosterone and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Dehydroepiandrosterone supplementation attenuates ovarian ageing in a galactose-induced primary ovarian insufficiency rat model.
Topics: Aging; Animals; Dehydroepiandrosterone; Dietary Supplements; Disease Models, Animal; Female; Galacto | 2019 |
Dehydroepiandrosterone supplementation attenuates ovarian ageing in a galactose-induced primary ovarian insufficiency rat model.
Topics: Aging; Animals; Dehydroepiandrosterone; Dietary Supplements; Disease Models, Animal; Female; Galacto | 2019 |
Dehydroepiandrosterone supplementation improves ovarian reserve and pregnancy rates in poor responders.
Topics: Adult; Dehydroepiandrosterone; Dietary Supplements; Female; Humans; Infertility, Female; Ovarian Res | 2020 |
Dehydroepiandrosterone supplementation improves ovarian reserve and pregnancy rates in poor responders.
Topics: Adult; Dehydroepiandrosterone; Dietary Supplements; Female; Humans; Infertility, Female; Ovarian Res | 2020 |
The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
Topics: Adult; Anti-Mullerian Hormone; Biomarkers; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimu | 2018 |
The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
Topics: Adult; Anti-Mullerian Hormone; Biomarkers; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimu | 2018 |
Premature ovarian insufficiency - novel hormonal approaches in optimizing fertility.
Topics: Adult; Dehydroepiandrosterone; Estradiol; Female; Fertility; Hormone Replacement Therapy; Humans; Pr | 2020 |
Premature ovarian insufficiency - novel hormonal approaches in optimizing fertility.
Topics: Adult; Dehydroepiandrosterone; Estradiol; Female; Fertility; Hormone Replacement Therapy; Humans; Pr | 2020 |
Dehydroepiandrosterone in women with premature ovarian failure and Hashimoto's thyroiditis.
Topics: Adolescent; Adult; Autoantibodies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estrogen | 2014 |
Dehydroepiandrosterone in women with premature ovarian failure and Hashimoto's thyroiditis.
Topics: Adolescent; Adult; Autoantibodies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estrogen | 2014 |
DHEA--finding a role for this enigmatic hormone.
Topics: Adult; Aging; Dehydroepiandrosterone; Dietary Supplements; Female; Humans; Pregnancy; Primary Ovaria | 2013 |
DHEA--finding a role for this enigmatic hormone.
Topics: Adult; Aging; Dehydroepiandrosterone; Dietary Supplements; Female; Humans; Pregnancy; Primary Ovaria | 2013 |
Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study.
Topics: Adult; Androgens; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Drug Synergism; Fema | 2014 |
Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study.
Topics: Adult; Androgens; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Drug Synergism; Fema | 2014 |
Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency.
Topics: Adult; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Fertility; Follicle Stimulating Horm | 2017 |
Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency.
Topics: Adult; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Fertility; Follicle Stimulating Horm | 2017 |
Dehydroepiandrosterone treatment of ovarian failure.
Topics: Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Primary Ovarian Insufficiency | 2009 |
Dehydroepiandrosterone treatment of ovarian failure.
Topics: Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Primary Ovarian Insufficiency | 2009 |
Hype or hope? Ethical and practical considerations with clinical research in women with diminished ovarian reserve.
Topics: Clinical Trials as Topic; Dehydroepiandrosterone; Female; Humans; Practice Guidelines as Topic; Preg | 2012 |
Hype or hope? Ethical and practical considerations with clinical research in women with diminished ovarian reserve.
Topics: Clinical Trials as Topic; Dehydroepiandrosterone; Female; Humans; Practice Guidelines as Topic; Preg | 2012 |
DHEA for poor responders: can treatment be justified in the absence of evidence?
Topics: Clinical Trials as Topic; Dehydroepiandrosterone; Female; Humans; Practice Guidelines as Topic; Preg | 2012 |
DHEA for poor responders: can treatment be justified in the absence of evidence?
Topics: Clinical Trials as Topic; Dehydroepiandrosterone; Female; Humans; Practice Guidelines as Topic; Preg | 2012 |
The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation.
Topics: Adult; Androgens; Cohort Studies; Dehydroepiandrosterone; Dietary Supplements; Female; Fertilization | 2012 |
The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation.
Topics: Adult; Androgens; Cohort Studies; Dehydroepiandrosterone; Dietary Supplements; Female; Fertilization | 2012 |
Evaluation of serum androgen levels in women with premature ovarian failure.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Cross-Sectional Studies; Dehydroepi | 2005 |
Evaluation of serum androgen levels in women with premature ovarian failure.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Cross-Sectional Studies; Dehydroepi | 2005 |
Undetectable salivary testosterone in young women with premature ovarian failure.
Topics: Adult; Androstenedione; Biomarkers; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Humans; | 2006 |
Undetectable salivary testosterone in young women with premature ovarian failure.
Topics: Adult; Androstenedione; Biomarkers; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Humans; | 2006 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function.
Topics: Adult; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone; Female; Humans; Infertility, Fe | 2007 |
Premature ovarian failure and dehydroepiandrosterone.
Topics: Adult; Dehydroepiandrosterone; Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hor | 2009 |
Premature ovarian failure and dehydroepiandrosterone.
Topics: Adult; Dehydroepiandrosterone; Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hor | 2009 |
Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Female; Humans; Menstruation; Primary Ovarian Insuff | 1997 |
Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Female; Humans; Menstruation; Primary Ovarian Insuff | 1997 |